Lincolnshire, Illinois – LyfeSci Research & Innovation has announced the acquisition of Clinically Media (https://clinicallymedia.com/). According to the company announcement LyfeSci Research & Innovation is a physician-founded, full-service clinical research organization (CRO) dedicated to transforming clinical research through patient-centered methodologies and strong partnerships. The company recently acquired Clinically Media, a patient recruitment specialist, to expand its end-to-end clinical trial capabilities and address challenges in timely and representative patient enrollment. This acquisition integrates data-driven, inclusive enrollment strategies directly into LyfeSci’s CRO model, enhancing their ability to connect study design, site selection, and recruitment execution. LyfeSci brings extensive experience across various therapeutic indications, with deep expertise in dermatology and central nervous system (CNS) research, including aesthetic medicine, psychiatry, and neurology. By combining clinical expertise with patient-focused innovation, LyfeSci aims to advance therapeutic development and improve health outcomes globally.

To learn more about LyfeSci Research & Innovation, visit https://www.lyfesci.com/
Company LinkedIn Page: https://www.linkedin.com/company/lyfesci-research-innovation/

Company Contact:

LyfeSci Research & Innovation
250 Parkway Dr, Ste. 150
Lincolnshire, IL 60069
844-593-3724

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.